HealthPolitics

STAT+: Up and down the ladder: The latest comings and goings

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 06/11/2026, 16:51:25 UTC.

Briefings

STAT+ reports that MetaVia hired Sarah Browne as chief medical officer, a role previously held by her at Altimmune and Souffle Therapeutics. This is the first update on Browne's career trajectory since her initial hiring announcement in November 2024. The article highlights her transition from clinical development roles to a senior leadership position at MetaVia.

Key points

• MetaVia hired Sarah Browne as chief medical officer in November 2024.
• Browne previously served as vice president, clinical development at Altimmune.

Context

STAT+ features a weekly profile of individuals moving between companies. This update specifically tracks Browne's progression from clinical development roles to a new leadership position at MetaVia.

Limitations

The article provides no information on Browne's tenure at MetaVia, her specific contributions, or the company's strategic direction. It also does not confirm if she was promoted or hired, only that she was hired. The source does not specify the exact date of her hiring at MetaVia beyond the general November timeframe.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 07/11/2026, 04:14:01 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeifsmluyuzgxtxfvqsnovdouka4qbzwzxjnrci4t3okwklqi3lv4c4